KAPA 8-K 2026-11-05

Kairos Pharma, LTD. (KAPA) 8-K dated 2026-11-05 — accession 0001493152-26-050094.

Kairos Pharma, LTD. (KAPA) is a biotechnology company listed on US.

Kairos Pharma, LTD. filed a 8-K on 2026-11-05. Accession 0001493152-26-050094.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for KAPA is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The KAPA SEC hub lists recent forms. The stock page is the research view.